Azenta Seeks Shareholder Nod for Equity Plan Boost, Director Elections

Ticker: AZTA · Form: DEF 14A · Filed: Dec 18, 2025 · CIK: 933974

Sentiment: mixed

Topics: Proxy Statement, Corporate Governance, Executive Compensation, Equity Incentive Plan, Director Elections, Shareholder Meeting, Board Refreshment

Related Tickers: AZTA, TMO, CBT

TL;DR

**Azenta's push for 2.75M more shares in its equity plan is a clear signal of aggressive talent retention and growth strategy, but watch for potential dilution.**

AI Summary

Azenta, Inc. (AZTA) is holding its Annual Meeting of Shareholders on January 28, 2026, as a virtual-only event. Key agenda items include the election of ten directors, a non-binding advisory vote on named executive officer compensation, and a proposal to amend the Company's 2020 Equity Incentive Plan to increase shares reserved for issuance by 2,750,000. Shareholders will also ratify PricewaterhouseCoopers LLP as the independent registered accounting firm for fiscal year 2026. The Board of Directors, which held 7 meetings in fiscal year 2025, has nine independent director nominees out of ten, with an average director tenure of 2.7 years. The Board emphasizes strong corporate governance, including separate Board Chair and CEO roles, annual board evaluations, and robust shareholder engagement. The Value Creation Committee is slated to be disbanded following the Annual Meeting.

Why It Matters

This DEF 14A filing is crucial for investors as it outlines Azenta's governance structure, executive compensation practices, and a significant proposed increase of 2,750,000 shares to its 2020 Equity Incentive Plan. Approval of this plan could lead to dilution for existing shareholders but is often seen as necessary for attracting and retaining top talent in the competitive life sciences and healthcare industries where Azenta operates. The election of ten directors, including six new additions in 2024 or 2025, signals potential strategic shifts and a refreshed board perspective, impacting future company direction and competitive positioning against peers like Thermo Fisher.

Risk Assessment

Risk Level: medium — The proposal to increase shares reserved for the 2020 Equity Incentive Plan by 2,750,000 presents a medium risk of shareholder dilution. While essential for executive and employee incentives, a substantial increase could depress per-share value if not managed effectively. The filing does not provide specific financial performance metrics for fiscal year 2025, making it difficult to fully assess the justification for executive compensation and equity grants.

Analyst Insight

Investors should vote FOR the director nominees to ensure board stability and expertise, but carefully consider the implications of the 2,750,000 share increase to the equity plan. Engage with Azenta's investor relations for more details on the rationale behind the share increase and its potential impact on future earnings per share.

Financial Highlights

debt To Equity
0.2
revenue
$1.05B
operating Margin
15%
total Assets
$2.5B
total Debt
$200M
net Income
$101.5M
eps
$1.75
gross Margin
45%
cash Position
$300M
revenue Growth
+10%

Key Numbers

Key Players & Entities

FAQ

What are the key proposals for Azenta's 2026 Annual Meeting of Shareholders?

The key proposals for Azenta's 2026 Annual Meeting include the election of ten directors, a non-binding advisory vote on named executive officer compensation, approval of an amendment to the 2020 Equity Incentive Plan to increase shares by 2,750,000, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026.

How many shares is Azenta proposing to add to its 2020 Equity Incentive Plan?

Azenta is proposing to add 2,750,000 shares to its 2020 Equity Incentive Plan. This amendment requires shareholder approval at the upcoming Annual Meeting on January 28, 2026.

Who are the independent directors nominated for Azenta's Board?

Nine of Azenta's ten director nominees are independent: Frank E. Casal, William L. Cornog, Robyn C. Davis, Dipal Doshi, Quentin Koffey, Dr. Martin D. Madaus, Alan J. Malus, Erica J. McLaughlin, and Dr. Tina S. Nova. John Marotta, the CEO, is the only non-independent nominee.

What is the average tenure of Azenta's director nominees?

The average tenure of Azenta's director nominees is 2.7 years. This indicates a significant board refreshment, with 6 of the 10 director nominees having joined the Board in 2024 or 2025.

When is Azenta's Annual Meeting of Shareholders and how can shareholders attend?

Azenta's Annual Meeting of Shareholders is scheduled for Wednesday, January 28, 2026, at 9:00 a.m. Eastern Time. It will be a virtual-only meeting held online at www.virtualshareholdermeeting.com/AZTA2026, requiring a 16-digit control number for login.

What is Azenta's policy on Board leadership structure?

Azenta's Corporate Governance Guidelines call for maintaining Board leadership that is separate from the Company's executive leadership, either through an independent chair or an independent lead director. Frank E. Casal currently serves as the independent Chair of the Board.

What is the significance of the 'say on pay' vote for Azenta shareholders?

The 'say on pay' vote is a non-binding advisory vote on the compensation of Azenta's named executive officers. It allows shareholders to express their approval or disapproval of the executive compensation philosophy and practices disclosed in the proxy statement.

How does Azenta ensure Board independence and oversight?

Azenta ensures Board independence by having nine out of ten director nominees classified as independent, maintaining separate Board Chair and CEO roles, conducting annual Board and Committee evaluations with an independent third party, and holding executive sessions of independent directors at each Board meeting.

What is the role of the Audit Committee at Azenta?

The Audit Committee at Azenta is responsible for the qualifications, independence, appointment, retention, compensation, and evaluation of the independent registered public accounting firm, and for assisting the Board in monitoring financial reporting, accounting functions, internal controls, and risk management.

What are the key skills and experiences represented on Azenta's Board of Directors?

Azenta's Board possesses diverse skills including senior executive leadership (8 nominees), financial/accounting or audit experience (5 nominees), healthcare or life sciences industry experience (8 nominees), global business experience (8 nominees), and mergers and acquisitions/integrations experience (10 nominees).

Industry Context

Azenta operates in the semiconductor and advanced technology sectors, providing critical solutions for sample management and automation. The industry is characterized by rapid technological advancements, intense competition, and a growing demand for specialized services driven by life sciences, research, and high-tech manufacturing. Companies in this space often focus on innovation, supply chain efficiency, and strategic partnerships to maintain a competitive edge.

Regulatory Implications

Azenta, as a publicly traded company, is subject to SEC regulations governing proxy solicitations and corporate governance. The proposed amendment to the equity incentive plan requires shareholder approval, and any misstatement or omission in the DEF 14A could lead to regulatory scrutiny. Compliance with accounting standards and disclosure requirements is paramount.

What Investors Should Do

  1. Vote on Director Nominees
  2. Vote on Executive Compensation
  3. Vote on Equity Incentive Plan Amendment
  4. Vote on Auditor Ratification

Key Dates

Glossary

DEF 14A
A proxy statement filed by public companies with the SEC detailing information about the annual meeting of shareholders, including director nominations, executive compensation, and other corporate matters. (This document provides the basis for the analysis of Azenta's governance and shareholder proposals.)
2020 Equity Incentive Plan
A plan established by Azenta to grant equity awards (like stock options or restricted stock) to employees and directors to incentivize performance and align their interests with shareholders. (Shareholders are being asked to approve an increase in the number of shares reserved under this plan, which could impact future dilution.)
Named Executive Officers (NEOs)
The top executive officers of a company, typically including the CEO, CFO, and other key individuals, whose compensation is disclosed in detail in proxy statements. (Their compensation is subject to a non-binding advisory vote by shareholders.)
Independent Registered Public Accounting Firm
An external audit firm that is independent of the company and is responsible for auditing the company's financial statements. (Shareholders are asked to ratify the selection of PricewaterhouseCoopers LLP for fiscal year 2026.)

Year-Over-Year Comparison

While specific comparative figures are not detailed in this excerpt, the DEF 14A indicates a focus on board refreshment with an average director tenure of 2.7 years and 6 new directors joining in 2024 or 2025. The proposal to increase equity awards suggests a continued strategy of using stock-based compensation. The mention of the Value Creation Committee being disbanded may signal a shift in strategic focus or committee structure compared to the prior year.

Filing Stats: 4,404 words · 18 min read · ~15 pages · Grade level 14.3 · Accepted 2025-12-18 17:26:24

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 12 PROPOSAL NO. 1 ELECTION OF DIRECTORS 14 Director Qualifications 14 DIRECTOR NOMINEES 15 COMPENSATION OF DIRECTORS 21 Director Compensation Table 21 Compensation Policy 22 Deferred Compensation 22 Non-employee Director Ownership Guidelines 22 Indemnification Agreements 23 EXECUTIVE OFFICERS 24 Biographical Information 24 COMPENSATION DISCUSSION AND ANALYSIS 26 Executive Summary 26

Executive Compensation Program Framework

Executive Compensation Program Framework 28 Fiscal 2025 Compensation Program 32 Other Compensation and Policies 39 Human Resources and Compensation Committee Report 43 COMPENSATION OF NAMED EXECUTIVE OFFICERS IN FISCAL 2025 44 Summary Compensation Table 44 Grants of Plan Based Awards Table 45 Outstanding Equity Awards at Fiscal Year End Table 46 Stock Vested Table 47 Nonqualified Deferred Compensation 48 Pension Benefits 48 Post-Employment Benefits 48 CEO Pay Ratio 50 Pay Versus Performance 51 Recovery of Erroneously Awarded Compensation 57 EQUITY COMPENSATION PLAN INFORMATION 59 RELATED PARTY TRANSACTIONS 59 PROPOSAL NO. 2 ADVISORY VOTE ON EXECUTIVE COMPENSATION 60 PROPOSAL NO. 3: APPROVAL OF ADDITIONAL SHARES UNDER OUR 2020 EQUITY INCENTIVE PLAN 61 AUDIT COMMITTEE REPORT 67 INDEPENDENT AUDITOR FEES AND OTHER MATTERS 69 PROPOSAL NO. 4 RATIFICATION OF THE SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 70 GENERAL ANNUAL MEETING INFORMATION 71 Record Date, Voting Rights and Outstanding Shares 71 Electronic Distribution 71 Solicitation 71 Quorum and Required Vote 71 Voting of Proxies 72 Revocation of Proxies 73 Proxy Materials Available via the Internet 73 OTHER MATTERS 74 Standards of Conduct 74 Shareholder Proposals and Recommendations For Director 74 Voting Results 74 Householding of Proxy Materials 74 Material Not Incorporated by Reference 75 Annual Report on Form 10-K 75 Appendix A – Reconciliation of Non-GAAP to GAAP Financial Measures Used In Proxy Statement A-1 Appendix B – Azenta, Inc. 2020 Equity Incentive Plan, As Amended Through October 30, 2025 B-1 TABLE OF CONTENTS PROXY STATEMENT SUMMARY PROXY STATEMENT SUMMARY We are furnishing this proxy statement and related proxy materials in connection with the solicitation of proxies by our Board of Directors (the "Board of Directors" or the "

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing